MedTrace Logo

Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant

NCT00815867 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2016-04-28

No results posted yet for this study

Summary

Main objective : Assessing the effect of epoetin beta on Hb rate and the glomerular filtration rate estimated 30 days after kidney transplant.

Conditions

Interventions

DRUG

epoetin beta (NeoRecormon ®)

comparison of administration of high dosage of epoetin vs no administration of epoetin 30000 UI: 4 injections

Sponsors & Collaborators

  • Roche Pharma AG

    collaborator INDUSTRY

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • CHOUKROUN Gabriel, Ph D · CHU Amiens

  • MARTINEZ Franck, Ph D · Necker Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2009-04-30
Completion
2009-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815867 on ClinicalTrials.gov